Active specific immunotherapy in the treatment of human cancers.
Mitchell
M S
MS
Department of Medicine, University of Southern California School of Medicine, Los Angeles.
D000276:Adjuvants, Immunologic; D002986:Clinical Trials as Topic; D006801:Humans; D007110:Immunity, Active; D007167:Immunotherapy; D007958:Leukocyte Count; D008050:Lipid A / Q000031:analogs & derivatives; D008545:Melanoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy; D009821:Oils; D013602:T-Lymphocytes, Cytotoxic / Q000473:pathology; D050378:T-Lymphocytes, Regulatory / Q000473:pathology; D014407:Tumor Cells, Cultured / Q000276:immunology; D014612:Vaccines
D000276:Adjuvants, Immunologic; D008050:Lipid A; D009821:Oils; D014612:Vaccines